Detalhe da pesquisa
1.
TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways.
Hepatobiliary Pancreat Dis Int
; 23(2): 195-209, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806848
2.
Bio-compatibility and cytotoxicity studies of water-soluble CuInS2-ZnS-AFP fluorescence probe in liver cancer cells.
Hepatobiliary Pancreat Dis Int
; 15(4): 406-11, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27498581
3.
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma.
Transl Oncol
; 21: 101441, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35523010
4.
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma.
Hepatobiliary Surg Nutr
; 11(6): 808-821, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523928
5.
Immune implication of FAM83D gene in hepatocellular carcinoma.
Bioengineered
; 12(1): 3578-3592, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34308751
6.
Revision and addendum to the manuscript titled "Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma".
Hepatobiliary Surg Nutr
; 12(3): 475-477, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351135
7.
Improvement of cytotoxicity of autologous CIKs from patients with breast cancer to MCF-7 cells by suppressed PD-1 expression.
Cancer Biomark
; 20(4): 609-615, 2017 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869441